The researchers performed targeted sequencing using Thermo Fisher Scientific's Oncomine Comprehensive Panel and the Ion Torrent PGM or Proton.
The partners will develop an NGS panel for solid and liquid tumors for use in personalized oncology.
Reimbursement from private insurers continues to grow, with United Healthcare recently saying it will cover molecular profiling for stage IV non-small cell lung cancer patients.
Under the terms of the agreement, N-of-One will provide clinical interpretation services for samples sequenced on a 50-gene hot-spot solid tumor panel.
The combined offering will enable customers to assess health outcomes and therapy effectiveness at the patient-anonymous level.
The Broad will partner with Dana-Farber/Harvard Cancer Center and Memorial Sloan Kettering Cancer Center on a large tumor sequencing study.
During a conference call, management discussed new commercial initiatives and investments, reimbursement progress, and its partnership with Roche.
In Science this week: measles virus nucleocapsid structure, and more.
Among other initiatives, the firms will develop new molecular and companion diagnostic tests and kits, while Roche will sell Foundation's tests outside the US.
NEW YORK (GenomeWeb News) – A study in Nature Genetics suggests alterations to two chromatin-remodeling genes — ARID1A and ARID1B — are linked to particularly poor neuroblastoma outcomes.
According to Gizmodo, researchers have developed a list of a million nucleic acid-like polymers that could store genetic information.
An opinion piece in the Washington Post argues that golden rice could save the sight and lives of many children.
US National Institutes of Health has issued a new draft data-sharing policy, ScienceInsider reports.
In Cell this week: analysis of immune microenvironment in hepatocellular carcinoma, proteogenomic analysis of clear cell renal cell carcinoma, and more.